AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bactiguard Holding

Regulatory Filings Jul 1, 2015

3004_rns_2015-07-01_629d591c-5047-4de3-ba9d-9bb64f71744a.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Press release Stockholm 1 July, 2015

Delivery to Saudi Arabia

Bactiguard delivers an order of more than 20 000 Foley catheters for infection control to Saudi Arabia.

At the end of June, Bactiguard delivered an order of more than 20 000 Foley catheters to Gulf Medical in Saudi Arabia. Gulf Medical distributes Bactiguard's portfolio of products for infection control to the healthcare system in both Saudia Arabia and the United Arab Emirates (UAE).

"We are very pleased about the increased interest from the healthcare system in Saudi Arabia and UAE to combat hospital acquired infections at the source. Preventive measures will become more and more important as multi resistant bacteria continue to spread across the world. Bactiguard provides solutions which are both effective and cost-efficent," says Christian Kinch, CEO.

This is information that Bactiguard Holding AB (publ) is required to publish in compliance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 1 July 2015 at 08:00

For further information, please contact:

Cecilia Edström, Acting Director of Sales, Marketing & Communications, [email protected], mobile: +46 722 262 328

About Bactiguard

Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company's patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, Latin America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters are located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.